Strain rate echocardiography uncovers subclinical left ventricular dysfunction in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 14, Issue 5, 2015, Pages 654-660

  Sellers, Zachary M ^a   McGlocklin, Lori ^b   Brasch, Andrea ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b CARLE FOUNDATION HOSPITAL   (United States)

Author keywords

Cystic fibrosis; Echocardiography; Heart function; Left ventricle; Strain imaging

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HEART DISEASE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; MALE; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; COMPLICATION; CYSTIC FIBROSIS; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; ETIOLOGY; FOLLOW UP; FORCED EXPIRATORY FLOW; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ADULT; CYSTIC FIBROSIS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY FLOW RATES; HUMANS; MALE; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84940957838     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2015.03.010     Document Type: Article

References (29)

1. - channel resembles the cystic fibrosis transmembrane conductance regulator. Nature 1992, 360:81-84.
2. Ambrosi P., Chazalettes J.P., Viard L., Raynaud M., Faugere G., Noirclerc M., et al. Left ventricular involvement in mucoviscidosis after 2years of age. Arch Fr Pediatr 1993, 50:653-656.
3. Cheron G., Paradis K., Steru D., Demay G., Lenoir G. Cardiac involvement in cystic fibrosis revealed by a ventricular arrhythmia. Acta Paediatr Scand 1984, 73:697-700.
4. Zebrak J., Skuza B., Pogorzelski A., Ligarska R., Kopytko E., Pawlik J., et al. Partial CFTR genotyping and characterisation of cystic fibrosis patients with myocardial fibrosis and necrosis. Clin Genet 2000, 57:56-60.
5. D'Hooge J., Heimdal A., Jamal F., Kukulski T., Bijnens B., Rademakers F., et al. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr 2000, 1:154-170.
6. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006, 7:79-108.
7. Nagueh S.F., Appleton C.P., Gillebert T.C., Marino P.N., Oh J.K., Smiseth O.A., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009, 10:165-193.
8. Dalen H., Thorstensen A., Aase S.A., Ingul C.B., Torp H., Vatten L.J., et al. Segmental and global longitudinal strain and strain rate based on echocardiography of 1266 healthy individuals: the HUNT study in Norway. Eur J Echocardiogr 2010, 11:176-183.
9. Stoylen A., Slordahl S., Skjelvan G.K., Heimdal A., Skjaerpe T. Strain rate imaging in normal and reduced diastolic function: comparison with pulsed Doppler tissue imaging of the mitral annulus. J Am Soc Echocardiogr 2001, 14:264-274.
10. Fine N.M., Shah A.A., Han I.Y., Yu Y., Hsiao J.F., Koshino Y., et al. Left and right ventricular strain and strain rate measurement in normal adults using velocity vector imaging: an assessment of reference values and intersystem agreement. Int J Cardiovasc Imaging 2013, 29:571-580.
11. Labombarda F., Pellissier A., Ellafi M., Creveuil C., Ribault V., Laurans M., et al. Myocardial strain assessment in cystic fibrosis. J Am Soc Echocardiogr 2011, 24:1037-1045.
12. Ozcelik N., Shell R., Holtzlander M., Cua C. Decreased right ventricular function in healthy pediatric cystic fibrosis patients versus non-cystic fibrosis patients. Pediatr Cardiol 2013, 34:159-164.
13. Wiglesworth F.W. Fibrocystic disease of the pancreas. Am J Med Sci 1946, 212:351-365.
14. Vizza C.D., Lynch J.P., Ochoa L.L., Richardson G., Trulock E.P. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998, 113:576-583.
15. Panidis I.P., Ren J.F., Holsclaw D.S., Kotler M.N., Mintz G.S., Ross J. Cardiac function in patients with cystic fibrosis: evaluation by two-dimensional and Doppler echocardiography. J Am Coll Cardiol 1985, 6:701-706.
16. Chipps B.E., Alderson P.O., Roland J.M., Yang S., van Aswegen A., Martinez C.R., et al. Noninvasive evaluation of ventricular function in cystic fibrosis. J Pediatr 1979, 95:379-384.
17. Johnson G.L., Kanga J.F., Moffett C.B., Noonan J.A. Changes in left ventricular diastolic filling patterns by Doppler echocardiography in cystic fibrosis. Chest 1991, 99:646-650.
18. Koelling T.M., Dec G.W., Ginns L.C., Semigran M.J. Left ventricular diastolic function in patients with advanced cystic fibrosis. Chest 2003, 123:1488-1494.
19. Koyama J., Ray-Sequin P.A., Falk R.H. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 2003, 107:2446-2452.
20. Weytjens C., Franken P.R., D'Hooge J., Droogmans S., Cosyns B., Lahoutte T., et al. Doppler myocardial imaging in the diagnosis of early systolic left ventricular dysfunction in diabetic rats. Eur J Echocardiogr 2008, 9:326-333.
21. Koyama J., Falk R.H. Prognostic significance of strain Doppler imaging in light-chain amyloidosis. J Am Coll Cardiol Img 2010, 3:333-342.
22. - channel activity to maintain contraction rate. J Physiol 2010, 588:2417-2429.
23. Ling H., Zhang T., Pereira L., Means C.K., Cheng H., Gu Y., et al. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 2009, 119:1230-1240.
24. Zhang T., Johnson E.N., Gu Y., Morissette M.R., Sah V.P., Gigena M.S., et al. The cardiac-specific nuclear delta(B) isoform of Ca2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J Biol Chem 2002, 277:1261-1267.
25. Duan D.D., Ye L. Novel cardioprotective function of CFTR chloride channels against myocardial hypertrophy and heart failure. Circulation 2011, 124:A18267.
26. Sellers Z.M., Kovacs A., Weinheimer C.J., Best P.M. Left ventricular and aortic dysfunction in cystic fibrosis mice. J Cyst Fibros 2013, 12:517-524.
27. Stephenson A.L., Mannik L.A., Walsh S., Brotherwood M., Robert R., Darling P.B., et al. Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study. Am J Clin Nutr 2013, 97:872-877.
28. Ishimo M.C., Belson L., Ziai S., Levy E., Berthiaume Y., Coderre L., et al. Hypertriglyceridemia is associated with insulin levels in adult cystic fibrosis patients. J Cyst Fibros 2013, 12:271-276.
29. Rhodes B., Nash E.F., Tullis E., Pencharz P.B., Brotherwood M., Dupuis A., et al. Prevalence of dyslipidemia in adults with cystic fibrosis. J Cyst Fibros 2010, 9:24-28.